Veeva Systems

Veeva Announces Fiscal 2024 Second Quarter Results

Retrieved on: 
Wednesday, August 30, 2023
Partnership, Q&A, Innovation, TFC, Patient, CRM, CFO, Growth, NYSE, Telecommunications, Management, Video game, Life insurance, Cryptocurrency, Veeva Systems

PLEASANTON, Calif., Aug. 30, 2023 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2023.

Key Points: 
  • Fiscal 2024 Second Quarter Results:
    Revenues: Total revenues for the second quarter were $590.2 million, up from $534.2 million one year ago, an increase of 10% year over year.
  • Veeva Announces Vault CRM Milestones — Veeva recently announced the first Vault CRM customer win, less than a year since announcing the migration of its market leading Veeva CRM solution to the Veeva Vault Platform.
  • Veeva is providing guidance for its fiscal third quarter ending October 31, 2023 as follows:
    Total revenues between $614 and $616 million.
  • Veeva is providing updated guidance for its fiscal year ending January 31, 2024 as follows:
    Total revenues between $2,365 and $2,370 million.

Veeva Announces First Customer Win and April 2024 Availability for Vault CRM - the Next Generation of CRM for Life Sciences

Retrieved on: 
Tuesday, August 29, 2023
Salesforce, NYSE, CRM, Sales, Veeva Systems

BARCELONA, Spain, Aug. 29, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced two major milestones as it advances Vault CRM – the next generation of CRM for the life sciences industry. Vault CRM had its first customer win with an innovative oncology biotech. The early adopter plans to go live starting with their field medical team in Q4 2023. Veeva also announced plans for the general release of Vault CRM in April 2024.

Key Points: 
  • Veeva also announced plans for the general release of Vault CRM in April 2024.
  • "The Veeva product team has made remarkable progress since we announced Vault CRM less than a year ago," said Tom Schwenger, Veeva president and COO.
  • Built on the Veeva Vault Platform for the unique needs of life sciences, Vault CRM will include all the functionality of market-leading Veeva CRM and new omnichannel capabilities.
  • The current Veeva CRM solution built on the Salesforce platform will enter stability mode after its final functional release in December 2023 to minimize change and provide a smooth migration path to Vault CRM for existing Veeva CRM customers.

Veeva Announces First Customer Win and April 2024 Availability for Vault CRM - the Next Generation of CRM for Life Sciences

Retrieved on: 
Monday, August 28, 2023
Salesforce, NYSE, CRM, Sales, Veeva Systems

PLEASANTON, Calif., Aug. 28, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced two major milestones as it advances Vault CRM – the next generation of CRM for the life sciences industry. Vault CRM had its first customer win with an innovative oncology biotech. The early adopter plans to go live starting with their field medical team in Q4 2023. Veeva also announced plans for the general release of Vault CRM in April 2024.

Key Points: 
  • Veeva also announced plans for the general release of Vault CRM in April 2024.
  • "The Veeva product team has made remarkable progress since we announced Vault CRM less than a year ago," said Tom Schwenger, Veeva president and COO.
  • Built on the Veeva Vault Platform for the unique needs of life sciences, Vault CRM will include all the functionality of market-leading Veeva CRM and new omnichannel capabilities.
  • The current Veeva CRM solution built on the Salesforce platform will enter stability mode after its final functional release in December 2023 to minimize change and provide a smooth migration path to Vault CRM for existing Veeva CRM customers.

Veeva Vault LIMS to Support Civica Rx Quality Control

Retrieved on: 
Tuesday, August 22, 2023
Civica Rx, Quality control, Civica, LIMS, Veeva Systems, QC, Patient, NYSE, Locksmithing, Entertainment

PLEASANTON, Calif., Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica's success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.

Key Points: 
  • PLEASANTON, Calif., Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control.
  • Vault LIMS builds on Civica's success with Veeva Vault QMS , Veeva Vault QualityDocs , and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.
  • Within Vault LIMS, lab professionals will be able to reference relevant methods and specifications stored in Vault QualityDocs and surface relevant quality events from Vault QMS during final QC review.
  • "Veeva Vault LIMS will help Civica create an advanced quality control lab with a simple and efficient user experience," said Jason Boyd, senior director, Veeva Vault LIMS.

Veeva Vault LIMS to Support Civica Rx Quality Control

Retrieved on: 
Tuesday, August 22, 2023
Civica Rx, Quality control, Civica, LIMS, Veeva Systems, QC, Patient, NYSE, Locksmithing

BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica's success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.

Key Points: 
  • BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control.
  • Vault LIMS builds on Civica's success with Veeva Vault QMS , Veeva Vault QualityDocs , and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.
  • Within Vault LIMS, lab professionals will be able to reference relevant methods and specifications stored in Vault QualityDocs and surface relevant quality events from Vault QMS during final QC review.
  • "Veeva Vault LIMS will help Civica create an advanced quality control lab with a simple and efficient user experience," said Jason Boyd, senior director, Veeva Vault LIMS.

Veeva R&D and Quality Summit Brings Together Biopharma Leaders to Accelerate Innovation

Retrieved on: 
Thursday, August 17, 2023
Cloud, CRISPR, Takeda, Align Biopharma, Bristol Myers Squibb, Amylyx Pharmaceuticals, Veeva Systems, Patient, GxP, Daiichi Sankyo, Jazz Pharmaceuticals, Merck, CRISPR Therapeutics, NYSE, ChromeOS, Safety, Pharmaceutical industry, Amgen, Sanofi

PLEASANTON, Calif.,  Aug. 17, 2023  /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that visionaries from Amgen, Bristol Myers Squibb, Daiichi Sankyo, Merck, and Takeda will be keynote speakers at the upcoming 2023 Veeva R&D and Quality Summit in Boston on Sept. 13 and 14. Biopharma leaders will share how new strategies and technology across clinical, regulatory, safety, and quality are moving the industry forward with speed and efficiency.

Key Points: 
  • Biopharma leaders will share how new strategies and technology across clinical, regulatory, safety, and quality are moving the industry forward with speed and efficiency.
  • As one of the largest life sciences events, Veeva R&D and Quality Summit will bring together more than 2,000 executives to share learnings across more than 90 sessions.
  • Additional featured keynotes and sessions include:
    Amgen shares its journey to simplify and improve the user experience across GxP quality management.
  • "Veeva R&D and Quality Summit brings together life sciences leaders from across the globe to learn, share insights, and innovate," said Jim Reilly, vice president of Veeva Development Cloud strategy.

Veeva to Release Fiscal 2024 Second Quarter Results on August 30, 2023

Retrieved on: 
Tuesday, August 8, 2023
Veeva Systems, NYSE, Communications satellite, Cryptocurrency

PLEASANTON, Calif., Aug. 8, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2023, after market close on August 30, 2023.

Key Points: 
  • PLEASANTON, Calif., Aug. 8, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2023, after market close on August 30, 2023.
  • Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m.
  • Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m.
  • ET).

Veho Appoints Seasoned Public Company CEO and Growth Strategist Dan Goldsmith to Board of Directors

Retrieved on: 
Tuesday, August 8, 2023
IPO, Goldsmith, Saks, Tendō, Tiger Global Management, Believer, SoftBank Vision Fund, OTD, Veeva Systems, Nespresso, HelloFresh, Management, Retail, Nordstrom, Veho

NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Veho , the company revolutionizing package delivery and returns for the modern economy, today appointed Dan Goldsmith to its Board of Directors.

Key Points: 
  • NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Veho , the company revolutionizing package delivery and returns for the modern economy, today appointed Dan Goldsmith to its Board of Directors.
  • Goldsmith is the CEO of Tendo, a software company providing seamless, consumer-driven experiences throughout the healthcare journey.
  • Goldsmith has been a trusted advisor and believer in Veho’s mission since backing the company as a seed investor in 2019.
  • His experience scaling high growth, high potential businesses will be valuable as we take Veho’s revenue growth to the next level,” said Itamar Zur, CEO and co-founder of Veho.

Norgine Expands Scientific Engagement with Veeva Link Key People

Retrieved on: 
Thursday, July 27, 2023
Cloud, Research, Veeva Systems, Patient, Congress, NYSE, Software, Mobile phone, Medical device

BARCELONA, Spain, July 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Norgine B.V. (Norgine), a leading European specialist pharmaceutical company, is using real-time customer intelligence from Veeva Link Key People to lead effective launch planning and engagement with experts as it expands to new therapeutic areas. Leveraging Link Key People in Europe, Australia, and New Zealand, Norgine's medical teams gain valuable market insights about top scientific, digital, and community leaders for greater visibility into scientific engagement across regions.

Key Points: 
  • Leveraging Link Key People in Europe, Australia, and New Zealand, Norgine's medical teams gain valuable market insights about top scientific, digital, and community leaders for greater visibility into scientific engagement across regions.
  • Veeva Link Key People helps us identify emerging and existing thought leaders and their scientific communities to make each interaction relevant to patient needs from the start."
  • "With Veeva Link Key People, Norgine can quickly engage the right experts and stay up to date on evolving trends to lead meaningful planning and engagement before and after launch."
  • Veeva Link 's connected data applications provide real-time intelligence across a number of areas, including key people, key accounts, scientific awareness, and medical insights.

Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption

Retrieved on: 
Wednesday, July 26, 2023
KOL, Lundbeck, Veeva Systems, HCO, MSL, Patient, NYSE, Library and Information Science Abstracts, Pharmaceutical industry, Medical device

PLEASANTON, Calif., July 26, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today revealed findings of field medical's impact on clinical practice in the Veeva Pulse Field Trends Report. Analysis shows that disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption. This result across the healthcare organization (HCO) within the first six months post-launch expands reach to more patients that could benefit from new medicines and therapies.

Key Points: 
  • Analysis shows that disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption.
  • Scientific engagement with KOLs has a lasting impact on new treatment adoption and most KOLs are asking for more interactions with MSLs.
  • Veeva Pulse analysis shows pre-launch field medical educational engagement with KOLs has a measurable benefit on new treatment adoption:
    MSL engagement with KOLs before launch drives 1.5 times greater treatment adoption.
  • "This deeper understanding of scientific engagement and treatment adoption shows the impact of field medical on launch success and most KOLs have greater potential to work with more field medical representatives to get the right medicine to the right patients faster," said Dan Rizzo, global head of Veeva business consulting.